|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004147,
umls-concept:C0007226,
umls-concept:C0008976,
umls-concept:C0020538,
umls-concept:C0026538,
umls-concept:C0026565,
umls-concept:C0126174,
umls-concept:C0301630,
umls-concept:C0376558,
umls-concept:C1522684,
umls-concept:C1948041,
umls-concept:C2349179,
umls-concept:C2603343
|
|
pubmed:issue |
9311
|
|
pubmed:dateCreated |
2002-4-8
|
|
pubmed:abstractText |
Blood pressure reduction achieved with beta-blockers and diuretics is the best recorded intervention to date for prevention of cardiovascular morbidity and death in patients with hypertension. Left ventricular hypertrophy (LVH) is a strong independent indicator of risk of cardiovascular morbidity and death. We aimed to establish whether selective blocking of angiotensin II improves LVH beyond reducing blood pressure and, consequently, reduces cardiovascular morbidity and death.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/11937178-12091001,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11937178-12091002,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11937178-12091003,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11937178-12091004,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11937178-12091006,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11937178-12091007,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11937178-12091008,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11937178-12091009,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11937178-12091010,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11937178-12117453,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11937178-12117460,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11937178-12160492,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11937178-12387973,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11937178-12387974,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11937178-12402815,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11937178-12418826,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11937178-12517248,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11937178-12583975,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11937178-12583976,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11937178-12911842,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11937178-15288732
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0140-6736
|
|
pubmed:author |
pubmed-author:BeeversGarethG,
pubmed-author:DahlöfBjörnB,
pubmed-author:DevereuxRichard BRB,
pubmed-author:FyhrquistFrejF,
pubmed-author:IbsenHansH,
pubmed-author:JuliusStevoS,
pubmed-author:KjeldsenSverre ESE,
pubmed-author:KoonA LAL,
pubmed-author:KristianssonKristerK,
pubmed-author:Lederballe-PedersenOleO,
pubmed-author:LindholmLars HLH,
pubmed-author:NieminenMarkku SMS,
pubmed-author:OparilSuzanneS,
pubmed-author:OpdamHH,
pubmed-author:WedelHansH,
pubmed-author:de FaireUlfU
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
23
|
|
pubmed:volume |
359
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
995-1003
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:11937178-Aged,
pubmed-meshheading:11937178-Aged, 80 and over,
pubmed-meshheading:11937178-Angiotensin Receptor Antagonists,
pubmed-meshheading:11937178-Antihypertensive Agents,
pubmed-meshheading:11937178-Atenolol,
pubmed-meshheading:11937178-Cardiovascular Diseases,
pubmed-meshheading:11937178-Diabetes Complications,
pubmed-meshheading:11937178-Double-Blind Method,
pubmed-meshheading:11937178-Female,
pubmed-meshheading:11937178-Humans,
pubmed-meshheading:11937178-Hypertension,
pubmed-meshheading:11937178-Losartan,
pubmed-meshheading:11937178-Male,
pubmed-meshheading:11937178-Middle Aged
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
|
|
pubmed:affiliation |
Sahlgrenska University Hospital/Ostra, Gothenburg, Swede. bdahlof@scandinaviancri.se
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
